United States · FDA National Drug Code directory
Guanfacine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63304-926_536beff7-ed52-290c-e063-6294a90a0b2e
- Product NDC
- 63304-926
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guanfacine
- Labeler
- Sun Pharmaceutical Industries, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180817
- Source listing expiry
- 20271231
Source-listed ingredients
- GUANFACINE HYDROCHLORIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-01) · 63304-926-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-05) · 63304-926-05
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-30) · 63304-926-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →